Cargando…
Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomark...
Autores principales: | Srinivasan, Mythily, Meadows, Melinda L., Maxwell, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816886/ https://www.ncbi.nlm.nih.gov/pubmed/29487749 http://dx.doi.org/10.1155/2018/7463796 |
Ejemplares similares
-
Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
por: Machura, Edyta, et al.
Publicado: (2013) -
Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus
por: Bawah, Ahmed Tijani, et al.
Publicado: (2019) -
Literature-Based Discovery of Salivary Biomarkers for Type 2 Diabetes Mellitus
por: Srinivasan, Mythily, et al.
Publicado: (2015) -
Visfatin and resistin: Mediators of the pleiotropic effects of incretins?
por: Nakashima, Eitaro
Publicado: (2012) -
Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models
por: Estienne, Anthony, et al.
Publicado: (2019)